Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0700
0.00 (0.00%)
Jul 3, 2024, 10:18 AM EDT - Market closed
Nascent Biotech Statistics
Total Valuation
NBIO has a market cap or net worth of $11.88 million. The enterprise value is $11.38 million.
Market Cap | 11.88M |
Enterprise Value | 11.38M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NBIO has 169.73 million shares outstanding. The number of shares has increased by 39.95% in one year.
Shares Outstanding | 169.73M |
Shares Change (YoY) | +39.95% |
Shares Change (QoQ) | +12.64% |
Owned by Insiders (%) | 48.76% |
Owned by Institutions (%) | 0.63% |
Float | 94.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 391.25 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 4.12.
Current Ratio | 1.05 |
Quick Ratio | n/a |
Debt / Equity | 4.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.66 |
Financial Efficiency
Return on equity (ROE) is -6,892.89% and return on invested capital (ROIC) is -1,450.55%.
Return on Equity (ROE) | -6,892.89% |
Return on Assets (ROA) | -326.40% |
Return on Capital (ROIC) | -1,450.55% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -152,271 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.86% in the last 52 weeks. The beta is -3.14, so NBIO's price volatility has been lower than the market average.
Beta (5Y) | -3.14 |
52-Week Price Change | +42.86% |
50-Day Moving Average | 0.09 |
200-Day Moving Average | 0.13 |
Relative Strength Index (RSI) | 46.29 |
Average Volume (20 Days) | 38,036 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | -2 |
Operating Income | -2.25M |
Pretax Income | -2.09M |
Net Income | -2.09M |
EBITDA | -2.25M |
EBIT | -2.87M |
Earnings Per Share (EPS) | -$0.01 |
Balance Sheet
The company has $623,854 in cash and $125,000 in debt, giving a net cash position of $498,854 or $0.00 per share.
Cash & Cash Equivalents | 623,854 |
Total Debt | 125,000 |
Net Cash | 498,854 |
Net Cash Per Share | $0.00 |
Equity (Book Value) | 30,367 |
Book Value Per Share | 0.00 |
Working Capital | 30,366 |
Cash Flow
Operating Cash Flow | -1.22M |
Capital Expenditures | n/a |
Free Cash Flow | -1.22M |
FCF Per Share | -$0.01 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NBIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -39.95% |
Shareholder Yield | -39.95% |
Earnings Yield | -17.62% |
FCF Yield | -10.28% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |